Frontage deal bolsters PRA’s lab services business
Contract research organisation PRA International has signed an agreement with fellow US firm Frontage Laboratories to expand the range of laboratory services it can offer to its clients.
Archives for December 8, 2008
Judge warns Commission over patent changes
A UK judge has warned against the European Commission making rash changes following its report into big pharma blocking generics, arguing that it could damage development of new drugs.
Departure debacle: Hermelin and KV part company
KV Pharmaceuticals’ long-serving CEO Marc Hermelin has either been sacked or has retired, depending on which party’s version of events one believes, and is being replaced by David Vliet CEO of the company’s Ethex division on an interim basis.
Icon boosts bioanalytical presence through Prevalere buy
Icon's recent $43.2m acquisition of New York-based Prevalere Life Sciences is the latest part of the firm's expansion in the US CRO market. Outsourcing-Pharma spoke with Icon's VP of bioanalytical development, Brian O'Dwyer, and Prevalere CEO Mario Rocci...
Bilcare boosts clinical trial supply business in India
India’s Bilcare has expanded its clinical trial materials business in its own market with the opening of new packaging and storage capacity at its facilities in Pune, India.
Haemacure seeks ruling in Hemaseel dispute
Haemacure is calling for the International Court of Arbitration in Paris, France to force CSL Behring to make a $1.5m milestone payment that it believes is now due under a 2002 settlement related to firms’ disputed Hemaseel project.